Resources

January 17, 2019

2018 Biosimilars – A Year in Review

The U.S. biologics and biosimilars markets evolved rapidly in 2018. In this webinar, life sciences attorneys John Adkisson, Tasha Francis, and Jenny Shmuel review the U.S. market for biosimilar products and provide insights into:

  • Which biosimilars have been approved and launched
  • Recent regulatory and legislative actions impacting the biosimilars market
  • Select court cases and settlements
  • Recent trends in IPR filings in the biosimilars space
  • What to look forward to in 2019
Speakers:
John Adkisson
Tasha Francis
Jenny Shmuel
No Comments

Sorry, the comment form is closed at this time.

Fill out the form below to receive our monthly newsletter and updates on your selected areas of interest. You can unsubscribe at any time by clicking the unsubscribe link at the bottom of the email.

  • Fish & Richardson P.C. is committed to protecting and respecting your privacy, and we’ll only use your personal information to administer your account and to provide the services you requested from us. From time to time, we would like to contact you about our services, as well as other content that may be of interest to you. If you consent to us contacting you for this purpose, please tick below.
  • In order to provide you the content requested, we need to store and process your personal data. If you consent to us storing your personal data for this purpose, please tick the checkbox below.
  • You can unsubscribe from these communications at any time. This can be done by clicking the unsubscribe link at the bottom of marketing emails you receive from us, or by emailing info@fr.com stating that you would like to be unsubscribed.
  • This field is for validation purposes and should be left unchanged.